Dry Powder Inhalers (DPI)

See our next Live Webinar on the topic of: Developing Reliable Capsule-Based Dry Powder Inhalers Overview The webinar will provide...

Abstract Background/Objectives: The stability and biological safety of newly developed formulations must be established to support their therapeutic efficacy and...

Introduction In the realm of pharmaceutical formulations, excipients are indispensable, enhancing the safety, efficacy, stability, manufacturability, and patient acceptability of...

Abstract Pulmonary delivery of poorly water-soluble drugs is constrained by the limited volume of epithelial lining fluid, heterogeneous aerosol deposition,...

Abstract As a major public health issue, chronic obstructive pulmonary disease (COPD) causes approximately 2.7 million deaths worldwide each year...

Abstract Capsule aperture geometry is a tunable design parameter that can markedly influence powder emission and aerosol dispersion in capsule-based...

Abstract Inhaled biologics to treat lung diseases have an extensive history. This is counterbalanced by the limited products that have...

Abstract Purpose To overcome the strong inter-particulate interactions between the drug and carrier in dry powder inhalers (DPIs), an amorphous...

Abstract Inhaled protein therapeutics offer a direct route to the lung and hold strong promise for improving respiratory disease treatment....

Abstract In this paper, the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), discusses the current regulatory landscape associated...